BACKGROUND: Studies evaluating risk factors for in-hospital venous thromboembolism in children are limited by quality assurance of case definition and/or lack of controlled comparison. The objective of this study is to determine risk factors for the development of in-hospital venous thromboembolism in children. DESIGN AND METHODS: In a case-control study at The Children's Hospital, Colorado, from 1(st) January 2003 to 31(st) December 2009 we employed diagnostic validation methods to determine pediatric in-hospital venous thromboembolism risk factors. Clinical data on putative risk factors were retrospectively collected from medical records of children with International Classification of Diseases, 9th edition codes of venous thromboembolism at discharge, in whom radiological reports confirmed venous thromboembolism and no signs/symptoms of venous thromboembolism were noted on admission. RESULTS: We verified 78 cases of in-hospital venous thromboembolism, yielding an average incidence of 5 per 10,000 hospitalized children per year. Logistical regression analyses revealed that mechanical ventilation, systemic infection, and hospitalization duration of five days or over were statistically significant, independent risk factors for in-hospital venous thromboembolism (OR=3.29, 95%CI=1.53-7.06, P=0.002; OR=3.05, 95%CI=1.57-5.94, P=0.001; and OR=1.03, 95%CI=1.01-1.04, P=0.001, respectively). Using these factors in a risk model, post-test probability of venous thromboembolism was 3.6%. CONCLUSIONS: These data indicate that risk of in-hospital venous thromboembolism in children with this risk factor combination may exceed that of hospitalized adults in whom prophylactic anticoagulation is indicated. Substantiation of these findings via multicenter studies could provide the basis for future risk-stratified randomized control trials of pediatric venous thromboembolism prevention.
BACKGROUND: Studies evaluating risk factors for in-hospital venous thromboembolism in children are limited by quality assurance of case definition and/or lack of controlled comparison. The objective of this study is to determine risk factors for the development of in-hospital venous thromboembolism in children. DESIGN AND METHODS: In a case-control study at The Children's Hospital, Colorado, from 1(st) January 2003 to 31(st) December 2009 we employed diagnostic validation methods to determine pediatric in-hospital venous thromboembolism risk factors. Clinical data on putative risk factors were retrospectively collected from medical records of children with International Classification of Diseases, 9th edition codes of venous thromboembolism at discharge, in whom radiological reports confirmed venous thromboembolism and no signs/symptoms of venous thromboembolism were noted on admission. RESULTS: We verified 78 cases of in-hospital venous thromboembolism, yielding an average incidence of 5 per 10,000 hospitalized children per year. Logistical regression analyses revealed that mechanical ventilation, systemic infection, and hospitalization duration of five days or over were statistically significant, independent risk factors for in-hospital venous thromboembolism (OR=3.29, 95%CI=1.53-7.06, P=0.002; OR=3.05, 95%CI=1.57-5.94, P=0.001; and OR=1.03, 95%CI=1.01-1.04, P=0.001, respectively). Using these factors in a risk model, post-test probability of venous thromboembolism was 3.6%. CONCLUSIONS: These data indicate that risk of in-hospital venous thromboembolism in children with this risk factor combination may exceed that of hospitalized adults in whom prophylactic anticoagulation is indicated. Substantiation of these findings via multicenter studies could provide the basis for future risk-stratified randomized control trials of pediatric venous thromboembolism prevention.
Authors: Vanesa Caruso; Licia Iacoviello; Augusto Di Castelnuovo; Sergio Storti; Guglielmo Mariani; Giovanni de Gaetano; Maria Benedetta Donati Journal: Blood Date: 2006-06-27 Impact factor: 22.113
Authors: Patricia Massicotte; Jim A Julian; Michael Gent; Karen Shields; Velma Marzinotto; Barbara Szechtman; Anthony K Chan; Maureen Andrew Journal: Thromb Res Date: 2003-01-25 Impact factor: 3.944
Authors: John A Sandoval; Michael P Sheehan; Charles E Stonerock; Shoaib Shafique; Frederick J Rescorla; Michael C Dalsing Journal: J Vasc Surg Date: 2008-03-04 Impact factor: 4.268
Authors: Ernest K Amankwah; Christie M Atchison; Shilpa Arlikar; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg Journal: Thromb Res Date: 2014-06-02 Impact factor: 3.944
Authors: Arash Mahajerin; Brian R Branchford; Ernest K Amankwah; Leslie Raffini; Elizabeth Chalmers; C Heleen van Ommen; Neil A Goldenberg Journal: Haematologica Date: 2015-05-22 Impact factor: 9.941
Authors: Joseph A Sujka; Katrina L Weaver; Justin A Sobrino; Ashwini Poola; Katherine W Gonzalez; Shawn D St Peter Journal: Pediatr Surg Int Date: 2018-12-03 Impact factor: 1.827
Authors: Christie M Atchison; Shilpa Arlikar; Ernest Amankwah; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg Journal: J Pediatr Date: 2014-07-23 Impact factor: 4.406
Authors: Jennifer Yen; Kyle J Van Arendonk; Michael B Streiff; LeAnn McNamara; F Dylan Stewart; Kim G Conner; Richard E Thompson; Elliott R Haut; Clifford M Takemoto Journal: Pediatr Crit Care Med Date: 2016-05 Impact factor: 3.624
Authors: Sheree L Boulet; Scott D Grosse; Courtney D Thornburg; Hussain Yusuf; James Tsai; W Craig Hooper Journal: Pediatrics Date: 2012-09-17 Impact factor: 7.124